Install
Latest in Discovery & Preclinical
Discovery & Preclinical at a glance
The 10 latest articles on Discovery & Preclinical come from 7 sources, published between Nov 11 and Nov 13. Most come from BIOENGINEER.ORG (4).
Organizations: FDA (2)
Places: China (2)
New obesity discovery rewrites decades of fat metabolism science
Science News from research organizations New obesity discovery rewrites decades of fat metabolism science Researchers have found that a hidden regulatory system helps determine how much fat the body keeps or loses. Date: November 24, 2025 Source: Université de Toulouse Summary: Researchers…
New Study on AfperFit™ Supplementation in Overweight Adults: Thermogenesis and Visceral Fat Loss
Partner Feature Paid for by Vidya The following content is provided by an advertiser or created on behalf of an advertiser. It is not written by the NutraIngredients Consolidated editorial team, nor does it necessarily reflect the opinions of NutraIngredients…
The Health Potential of Pine Terpenes and Bark Extracts
Top Health Categories ×Top Health Categories The Health Potential of Pine Terpenes and Bark Extracts if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } By Hugo Francisco de SouzaReviewed by Benedette Cuffari, M.Sc. IntroductionChemical Profile: Key Bioactive Terpenes & CompoundsPharmacological Mechanisms of…
VeonGen Announces Clinical Progress of VG801 Gene Therapy in Stargardt Disease, with an Oral Presentation at ARVO 2026
· VG801 shows encouraging preliminary efficacy in the ongoing Phase 1/2 trial, with consistent functional improvements in best-corrected visual acuity (BCVA) and Virtual Reality Visual Test (VRVT), sustained through six- and twelve-month follow-up · VG801 demonstrates a favorable safety profile, with no dose-limiting or serious…
Preclinical Data Show Annamycin Makes Pancreatic Cancer Responsive to Checkpoint Inhibitors, Opening a Combination Path with Immunotherapies
Live feedPRReleasevia QuantisnowPreclinical Data Show Annamycin Makes Pancreatic Cancer Responsive to Checkpoint Inhibitors, Opening a Combination Path with Immunotherapies ByQuantisnow·Nov 10, 2026 · 14:45:00 ET·Wall Street's wire, on your screen.Stocks in this Quantisnow insightHealth CareMBRXNASDAQMoleculin Biotech Inc.Alert me Ellis's readPreclinical…
Antengene Presents Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
Advertorial Antengene Presents Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026 By Antengene Corporation Limited Nov 11, 2026 6 hrs ago 0 4 min to read Logo SHANGHAI and HONG KONG, Nov. 11, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative,…
Discovery & Preclinical
Targets, assays, animal models, and early safety/tox studies before human trials.
- 2 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.